Related Experiment Videos
Synthetic oligodeoxynucleotides inhibit IgE induction in human lymphocytes
1Departments of Otorhinolaryngology and Immunology, Fukui Medical University, Fukui, Japan. sfujieda@fmsrsa.fukuimed.ac.jp
Summary
Synthetic oligodeoxynucleotides (ODNs) can inhibit immunoglobulin E (IgE) production in human cells. This discovery suggests ODNs may be a potential treatment for IgE-dependent allergic diseases.
Area of Science:
- Immunology
- Molecular Biology
- Allergy Research
Background:
- Unmethylated CpG motifs in synthetic oligodeoxynucleotides (ODNs) stimulate T-helper 1 (Th1) responses in mice.
- Th1 cytokines are known to downregulate immunoglobulin E (IgE) production.
Purpose of the Study:
- To investigate the inhibitory effect of synthetic ODNs on IgE production in human peripheral blood mononuclear cells (PBMCs).
- To explore the potential of synthetic ODNs as a therapeutic strategy for IgE-dependent allergic diseases.
Main Methods:
- Human PBMCs from normal donors were stimulated with interleukin (IL)-4 and anti-CD40 monoclonal antibody (mAb).
- Synthetic 30-mer single-stranded ODNs were selected and tested for their ability to inhibit IgE production.
- The role of interferon (IFN)-gamma and IL-12 in ODN-mediated suppression was assessed using blocking antibodies.
Main Results:
- Certain synthetic ODNs, specifically those with CGTACG or AACGTT motifs, inhibited IgE production by human PBMCs.
- ODNs containing NACGTTCG or A/CTCGTTCG sequences demonstrated specific inhibition of IgE production.
- The inhibitory effect was mediated by IFN-gamma and IL-12, as blocking antibodies neutralized the suppression.
- ODNs also inhibited the IL-4-induced upregulation of epsilon germline transcripts.
Conclusions:
- Synthetic ODNs can effectively inhibit IgE production in human PBMCs in vitro.
- The mechanism involves IFN-gamma and IL-12 signaling pathways.
- Synthetic ODNs show promise as potential therapeutic agents for treating IgE-dependent allergic conditions.